top of page
< Back

Muromonab CD3

莫羅單抗CD3

Mechanism of action:

Muromonab-CD3 是一種抗 CD3 的鼠源單株抗體(anti-CD3 murine monoclonal antibody)。Muromonab-CD3 會和 T 細胞的 CD3/TCR 複合體專一性結合,短暫促使 T 細胞釋放大量細胞激素(IL-2、TNF-α、IFN-γ),可能引發細胞激素釋放症候群(cytokine release syndrome)。但 muromonab-CD3 持續結合 CD3 之後,會誘發 T 細胞將 CD3/TCR 複合體內吞(endocytosis)、因訊號失衡進入細胞凋亡,或者引起巨噬細胞對這些 T 細胞進行抗體依賴性細胞吞噬作用(antibody-dependent cellular phagocytosis)。這使週邊血中成熟 T 細胞大量下降。

​Reference(s):

1. Todd PA et al. (1989). Muromonab CD3. A review of its pharmacology and therapeutic potential. Drugs. 


2. Wilde MI et al. (1996). Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection. Drugs.

bottom of page